Dr. Alice Peng, M.D

NPI: 1790712305
Total Payments
$816.54
2023 Payments
$26.35
Companies
9
Transactions
13
Medicare Patients
2,723
Medicare Billing
$455,577

Payment Breakdown by Category

Food & Beverage$446.55 (54.7%)
Other$300.00 (36.7%)
Education$69.99 (8.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $446.55 11 54.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $300.00 1 36.7%
Education $69.99 1 8.6%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $310.84 2 $0 (2018)
Novartis Pharmaceuticals Corporation $157.47 2 $0 (2017)
Relypsa, Inc. $106.01 1 $0 (2019)
SANOFI-AVENTIS U.S. LLC $69.99 1 $0 (2018)
Veloxis Pharmaceuticals, Inc. $62.31 2 $0 (2019)
Horizon Therapeutics plc $42.11 2 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $26.35 1 $0 (2023)
Alexion Pharmaceuticals, Inc. $20.89 1 $0 (2019)
Genentech USA, Inc. $20.57 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $26.35 1 Takeda Pharmaceuticals U.S.A., Inc. ($26.35)
2022 $42.11 2 Horizon Therapeutics plc ($42.11)
2019 $160.59 3 Relypsa, Inc. ($106.01)
2018 $380.83 3 GENZYME CORPORATION ($310.84)
2017 $206.66 4 Novartis Pharmaceuticals Corporation ($157.47)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/04/2023 Takeda Pharmaceuticals U.S.A., Inc. LIVTENCITY (Drug) Food and Beverage In-kind items and services $26.35 General
Category: IMMUNOLOGY
06/01/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.99 General
Category: KRYSTEXXA
05/04/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $20.12 General
Category: KRYSTEXXA
09/11/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $20.89 General
Category: Immunology
07/18/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $33.69 General
Category: Immunosuppressant
05/29/2019 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $106.01 General
Category: Hyperkalemia
11/08/2018 GENZYME CORPORATION THYMOGLOBULIN (Drug) Food and Beverage In-kind items and services $10.84 General
Category: ONCOLOGY
09/12/2018 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Education In-kind items and services $69.99 General
Category: ONCOLOGY
06/18/2018 GENZYME CORPORATION THYMOGLOBULIN (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $300.00 General
Category: ONCOLOGY
11/08/2017 Novartis Pharmaceuticals Corporation ZORTRESS (Drug) Food and Beverage In-kind items and services $39.39 General
Category: IMMUNOLOGY
10/30/2017 Genentech USA, Inc. Rituxan (Biological) Food and Beverage In-kind items and services $20.57 General
Category: BioOncology/Immunology
06/29/2017 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $118.08 General
03/30/2017 Veloxis Pharmaceuticals, Inc. Envarsus XR (Drug), Envarsus XR, Envarsus XR Food and Beverage In-kind items and services $28.62 General
Category: Immunosuppressant

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 793 1,251 $466,312 $119,968
2022 9 721 1,277 $483,629 $122,052
2021 12 599 1,031 $407,784 $111,501
2020 9 610 1,110 $391,567 $102,056
Total Patients
2,723
Total Services
4,669
Medicare Billing
$455,577
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 228 425 $197,960 $50,599 25.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 74 195 $70,135 $19,894 28.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 180 241 $77,374 $18,439 23.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 65 113 $27,202 $7,598 27.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 50 51 $31,446 $7,512 23.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 39 42 $17,829 $4,564 25.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 38 39 $14,024 $3,812 27.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 48 69 $9,678 $2,919 30.2%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 40 44 $13,724 $2,903 21.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 31 32 $6,940 $1,728 24.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 248 443 $209,867 $51,470 24.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 90 301 $99,319 $26,151 26.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 193 282 $90,101 $22,830 25.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 40 41 $26,172 $6,614 25.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 44 89 $20,449 $5,400 26.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 44 47 $16,075 $4,198 26.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 23 23 $9,995 $2,648 26.5%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 24 27 $8,680 $1,956 22.5%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 15 24 $2,971 $784.56 26.4%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 248 516 $221,457 $64,588 29.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 86 215 $72,146 $18,994 26.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 45 45 $29,179 $7,790 26.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 42 68 $15,868 $4,224 26.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 45 49 $13,812 $3,556 25.7%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 24 26 $11,528 $2,936 25.5%

About Dr. Alice Peng, M.D

Dr. Alice Peng, M.D is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790712305.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alice Peng, M.D has received a total of $816.54 in payments from pharmaceutical and medical device companies, with $26.35 received in 2023. These payments were reported across 13 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($446.55).

As a Medicare-enrolled provider, Peng has provided services to 2,723 Medicare beneficiaries, totaling 4,669 services with total Medicare billing of $455,577. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Nephrology
  • Location Los Angeles, CA
  • Active Since 06/27/2006
  • Last Updated 08/21/2014
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1790712305

Products in Payments

  • THYMOGLOBULIN (Drug) $310.84
  • Veltassa (Drug) $106.01
  • JEVTANA (Drug) $69.99
  • KRYSTEXXA (Biological) $42.11
  • ZORTRESS (Drug) $39.39
  • Envarsus (Drug) $33.69
  • Envarsus XR (Drug) $28.62
  • LIVTENCITY (Drug) $26.35
  • SOLIRIS (Drug) $20.89
  • Rituxan (Biological) $20.57

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Los Angeles